Equities
  • Price (USD)40.92
  • Today's Change0.14 / 0.34%
  • Shares traded45.89k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SDZ:SWX since
announced
Transaction
value
Coherus BioSciences Inc-CIMERLI BusinessDeal completed22 Jan 202422 Jan 2024Deal completed24.09%170.00m
Data delayed at least 15 minutes, as of Sep 20 2024 16:40 BST.

Institutional shareholders

0.43%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 05 Sep 2024882.37k0.21%
Dimensional Fund Advisors Ltd.as of 05 Sep 2024266.95k0.06%
DNCA Finance SAas of 31 Dec 2023193.05k0.05%
Jennison Associates LLCas of 31 Mar 2024118.90k0.03%
Altrinsic Global Advisors LLCas of 31 Mar 2024108.49k0.03%
Grantham, Mayo, Van Otterloo & Co. LLCas of 31 May 202493.26k0.02%
Ramirez Asset Management, Inc.as of 30 Jun 202486.41k0.02%
Henry James International Management, Inc.as of 30 Jun 202445.41k0.01%
Confluence Investment Management LLCas of 30 Jun 202426.30k0.01%
Picton Mahoney Asset Managementas of 31 Mar 202426.00k0.01%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.